Keyvan Koushan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keyvan Koushan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keyvan Koushan Today - Breaking & Trending Today

Higher Aflibercept Dose Safe as 2 mg

Published: August 2, 2023

The PULSAR trial of a higher dosage formulation extended the treatment interval to 12 or 16 weeks.

Source: medscape.com

Related Topics:

United KingdomUnited StatesDavid WongPhilip FerroneKeyvan KoushanJignesh PatelUniversity Of Toronto StColchester Hospitals University FoundationAmerican Society Of Retina SpecialistsToronto Retina InstituteAnnual MeetingAmerican SocietyColchester Hospitals University Foundation TrustVitreoretinal ConsultantsNew YorkAntiplatelet Trialists CollaborationRetina SpecialistsPresented JulyRetinal DiseaseMacular DegenerationGe Related Macular Degeneration ArmdBranch Retinal Artery OcclusionExudative Age Related Macular DegenerationXudative ArmdEye Problems